Publications

  • HOME
  • Publications
  • Publications
  • 162. A novel DDR1 Inhibitor Enhances the Anticancer Activity of Gemcitabine in Pancreatic Cancer

    Ko, S.; Jung, K.-H.; Yoon, Y.-C.; Han, B. S.; Park, M. S.; Lee, Y. J.; Kim, S. E.; Cho, Y. J.; Ryu, J. K.; Kim, K.; Kim, T. Y.; Hong, S.*; Lee, S. H.*; Hong, S.-S.*

    Am. J. Cancer Res. 2022, 12, 4326.

    QQPulsa

  • 161. N-Functionalized Pyridinium salts: A New Chapter for Site-Selective Pyridine C–H Functionalization via Radical-Based Processes under Visible Light Irradiation 

    Kim, M.; Koo, Y.; Hong, S.*  

    Acc. Chem. Res. 202255, 3043.

  • 160. Two-Track Virtual Screening Approach to Identify the Dual Inhibitors of Wild Type and C481S Mutant of Bruton’s Tyrosine Kinase

    Kim, T.;  Kim, K.; Park, I.; Hong, S.*; Park, H.*

    J. Chem. Inf. Model. 2022, 62, 4500 

  • 159. Oxidatively Induced Reactivity in Rh(III)-Catalyzed 7-Azaindole Synthesis: Insights into the Role of the Silver Additive

    Ryu, H.; Pudasaini, B.: Cho, D.; Hong, S.*; Baik, M.-H.* 

    Chem. Sci. 2022, 13, 10707.

  • 158. Site-Selective Pyridylic C–H Functionalization by Photocatalytic Radical Cascades 

    Kim, M.; You, E.; Kim, J.; Hong, S.* 

    Angew. Chem. Int. Ed. 2022, 61, e202204217.

    Highlighted as a Front Cover

    Selected as a Hot Paper 

  • 156. Discovery of a novel NUAK1 inhibitor against pancreatic cancer through inhibition of PI3K/AKT pathway

    Seo, M .S.: Jung, K. H.; Kim, K.; Lee, J. E.; Han, B. S.; Ko, S.; Hong, S.*; Lee, S. H.*; Hong, S.-S.*

    Biomed. Pharmacother. 2022, 152, 113241.

  • 155. Enantioselective Functionalization at the C4 Position of Pyridinium Salts through NHC Catalysis 

    Choi, H.; Mathi, G. R.; Hong, S.Hong, S.* 

    Nature Commun. 202213, 1776. 

  • 154. Regiodivergent Conversion of Alkenes to Branched or Linear Alkyl Pyridines 

    Kim. M.; Shin, S.; Koo, Y.; Jung, S.; Hong, S.* 

    Org. Lett. 2022, 24, 708.